Programa Personalizado de Pérdida de Peso con Apoyo de Medicación GLP-1

Several laboratory studies have demonstrated that GLP-1 Medications can achieve a greater degree of weight loss compared to other treatments. Some of its notable benefits include: Leads to a decrease in BMI*; Not addictive; non-habit-forming medication; Generally well-received by patients; Most patients experience minimal or no side effects; Offers a safe and effective treatment option; Slows down digestion; Decreases appetite and cravings; Rapidly induces feelings of fullness; Achieves substantial weight loss*; *Not guaranteed for all patients

Semaglutide is in a class of medications called incretin mimetics. It helps the pancreas to release the right amount of insulin when blood sugar levels are high. It is a similar molecule to what our bodies make, called a GLP-I analog. It also targets areas in the brain that regulates appetite and food intake. Semaglutide improves body composition by helping patients lose weight and reduce excess fat, including stubborn belly fat.

Semaglutide works in the following ways: Semaglutide delays how quickly our stomachs digest food, leading to a feeling of fullness and satisfaction with smaller meal sizes. The medication slows intestinal motility so you will feel fuller longer after meals. It lowers blood sugars, in part by reducing the production of sugar in the liver and stimulates insulin secretion by the pancreas.

Tirzepatide is a prescription medication used to treat type 2 diabetes and support weight loss and weight management. It's marketed under the brand names Mounjaro (for diabetes) and Zepbound (for obesity and related conditions).

Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it activates two gut hormone receptors that help regulate: Blood sugar levels — by increasing insulin release and reducing glucagon secretion. Appetite and digestion — by slowing stomach emptying and increasing feelings of fullness.

Nausea, diarrhea, constipation, or vomiting. Decreased appetite and mild abdominal pain. Rare but serious risks include pancreatitis, thyroid tumors, and gallbladder problems.

No. The Symliphy providers only prescribe FDA approved GLP-1 medications from brand manufacturers like Lilly and Novo Nordisk.

1. Clean the area you want to inject with an alcohol wipe and allow the skin to dry. Your abdomen (at least 2 inches away from your belly button), thigh (front or outer thigh), or upper arm are all good injection sites. But choose a spot that is at least a finger's width away from the last injection site. Change where you give the injection each time. You can inject in the same area of your body each time - just make sure it's not the same exact spot every time. Moving the injection spot is very important to minimize tissue damage to the area. 2. Hold the syringe with the needle facing toward the ceiling, push the plunger slightly until a drop of liquid forms at the end of needle. 3. Pinch and hold the skin that you will inject. 4. Holding the syringe directly at the pinched skin, quickly push the needle through the skin into the fat tissue, making sure to insert the entire length of the needle. Then, slowly push the plunger to inject all the medication. 5. Pull the needle out and clean the skin with an alcohol wipe. It's normal to see a drop of blood at the injection spot. Press gently on the site for a few seconds for the bleeding to stop. Discarding the syringe: Discard the syringe in the sharps container or a heavy plastic container with a tight-fitting lid. Do not throw away the syringe in your household trash.

Side effects include swelling/redness/itching at the injection site, tiredness, nausea, vomiting, diarrhea, or constipation can occur. Nausea usually lessens as you continue to use semaglutide. If any of these effects last or get worse, tell your doctor or pharmacist promptly. An allergic reaction is rare but get medical help immediately if you notice rash, itching, swelling (especially of the face/tongue/throat), severe dizziness or trouble breathing. The risk of serious side effects increases in patients with hypoglycemia, kidney problems, and risk of allergic reactions. Note: The 1mg/mL of Cyanocobalamin added to reduce nausea side effects. This is not a complete list of side effects, contact your doctor or pharmacist if you experience any abnormal effects of this medication. Warning: There is a risk of Thyroid C-Cell tumors. If you or any family members have been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or Medullary thyroid cancer you should not take Semaglutide. If you have ever had pancreatitis consult with your medical provider as using Semaglutide can increase the risk of developing pancreatitis.

All states except, CA, WA, IA.

There's no long-term commitment required in our program. It operates on a monthly basis, giving you the flexibility to assess your progress and decide whether to continue or pause your weight loss journey. Each month, a doctor will review your progress to ensure the medication remains safe and effective. You have the freedom to stop whenever you're satisfied with your results or choose to continue pursuing your weight loss goals.

To receive a prescription for GLP-1 medication, patients must first consult with a qualified healthcare provider. Typically, individuals with a BMI of 30 or higher are considered eligible candidates for this medication. However, those with a BMI as low as 27, as well as individuals managing certain medical conditions such as hypertension, type 2 diabetes, and high cholesterol, may also qualify for GLP-1 medication treatment. During the consultation, the healthcare provider conducts a comprehensive evaluation of the patient's medical history and current health status to determine their suitability for GLP-1 medication treatment. It's vital for patients to disclose any history of tumors or cancer, as these factors may influence eligibility. Additionally, patients are required to inform their practitioner about any medications they are currently taking to ensure a safe and tailored treatment plan.

No. The Symliphy Weight Loss program operates on a cash-only basis which allows us to provide one of the most affordable and accessible weight loss solutions in the market.

Once the provider sends the prescription to the manufacturers pharmacy you should receive your medication within 3 to 5 days.

Yes. We follow HIPAA rules to protect your private health care information. You can view our Privacy Policy for more information.

If you're eligible for treatment, our provider team will issue you a prescription.

To Refill Your Weight Loss Medication, please return to symliphy monthly to complete a new healthcare questionnaire. We recommend completing this step 6 days before you need additional medication.

For Lilly medications (Zepbound, Foundayo, etc.) - 1-844-LLYDIR1 (1-844-559-3471) and for Novo Nordisk medications (Wegovy, Ozempic, etc.) - 1-888-809-3942.

Yes, but only for your first month of treatment. Ongoing treatment requires a completed set of lab test results. The lab test is to help ensure the Weight Loss treatment is safe for you. The lab test will screen for liver, kidney, and thyroid function.